New York State Common Retirement Fund’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $594K | Buy |
|
|||||
|
2025
Q1 | $417K | Hold |
|
|||||
|
2024
Q4 | $418K | Hold |
|
|||||
|
2024
Q3 | $423K | Sell |
|
|||||
|
2024
Q2 | $527K | Buy |
|
|||||
|
2024
Q1 | $322K | Buy |
|
|||||
|
2023
Q4 | $354K | Sell |
|
|||||
|
2023
Q3 | $544K | Buy |
|
|||||
|
2023
Q2 | $439K | Sell |
|
|||||
|
2023
Q1 | $1.73M | Sell |
|
|||||
|
2022
Q4 | $2.79M | Buy |
|
|||||
|
2022
Q3 | $2.95M | Sell |
|
|||||
|
2022
Q2 | $2.5M | Sell |
|
|||||
|
2022
Q1 | $6.56M | Buy |
|
|||||
|
2021
Q4 | $2.7M | Buy |
|
|||||
|
2021
Q3 | $2.43M | Sell |
|
|||||
|
2021
Q2 | $3.18M | Sell |
|
|||||
|
2021
Q1 | $2.16M | Buy |
|
|||||
|
2020
Q4 | $1.11M | Buy |
|
|||||
|
2020
Q3 | $457K | Hold |
|
|||||
|
2020
Q2 | $634K | Hold |
|
|||||
|
2020
Q1 | $266K | Hold |
|
|||||
|
2019
Q4 | $459K | Buy |
|
|||||
|
2019
Q3 | $292K | Hold |
|
|||||
|
2019
Q2 | $386K | Hold |
|
|||||
|
2019
Q1 | $829K | Hold |
|
|||||
|
2018
Q4 | $822K | Hold |
|
|||||
|
2018
Q3 | $777K | Hold |
|
|||||
|
2018
Q2 | $583K | Hold |
|
|||||
|
2018
Q1 | $486K | Hold |
|
|||||
|
2017
Q4 | $500K | Buy |
|
|||||
|
2017
Q3 | $439K | Hold |
|
|||||
|
2017
Q2 | $466K | Buy |
|
|||||
|
2017
Q1 | $582K | Buy |
|
|||||
|
2016
Q4 | $439K | Hold |
|
|||||
|
2016
Q3 | $306K | Hold |
|
|||||
|
2016
Q2 | $197K | Hold |
|
|||||
|
2016
Q1 | $196K | Hold |
|
|||||
|
2015
Q4 | $715K | Hold |
|
|||||
|
2015
Q3 | $790K | Sell |
|
|||||
|
2015
Q2 | $1.11M | Buy |
|